Editorial team
ioQuanta Research Desk
-
Evidence date ·What plant fibers change in PBS strength, stretch and soil breakdown
Review or Meta-AnalysisA 2021 review finds cotton fibers can raise PBS strength while cutting stretch; abaca composites lost more weight in a 90-day soil test, but farm use remains unresolved.
-
Evidence date ·What must an orthodontic adhesive do beyond avoiding bisphenol A?
Review or Meta-AnalysisAvoiding bisphenol A does not settle a resin's safety: a 2021 review describes modified composites that released TEGDMA, another resin ingredient, in extraction tests.
-
Evidence date ·What do glycerol, plant fibres and other plastics change in a starch film?
Review or Meta-AnalysisA 2021 review reports a corn-starch blend that reached 35 MPa in a pull test, while moisture uptake and poor mixing with another plastic complicate packaging.
-
Evidence date ·What weaving changes in kenaf plant fiber composites
Review or Meta-AnalysisA 2021 review traces how weaving and resin bonding affect kenaf composites’ impact resistance, and why wider use in Malaysia remains difficult.
-
Evidence date ·What happened when researchers bent and twisted a lighter hood?
Peer-Reviewed PaperThe redesigned carbon-fiber hood was about 21% lighter than the first prototype and stiffer than a modeled steel hood in two bending tests.
-
Evidence date ·Some tumors responded after melanoma progressed on immune treatment, with side effects still part of the picture
Review or Meta-AnalysisAfter anti-PD-1 treatment failed in advanced melanoma, a 2021 review found some tumors shrank with ipilimumab alone or ipilimumab plus nivolumab.
-
Evidence date ·What held vaccine-primed T cells back in ovarian tumors?
Peer-Reviewed PaperIn mice, stimulating T cells improved survival with vaccination; an antibody that reduced granulocytic cells improved tumor control with checkpoint treatment.
-
Evidence date ·Why the bonds and gaps inside a plant-fiber composite matter
Review or Meta-AnalysisA 2021 review describes a hybrid composite study in which impact strength rose through 60% kenaf by volume, then fell at 75% amid voids and bonding flaws.
-
Evidence date ·Why does an RNA appear alongside an immune checkpoint marker in resistant ovarian cancer?
Peer-Reviewed PaperIn cisplatin-resistant ovarian cancer tissue, PVT1 and PD-L1 levels were associated. Lowering PVT1 also reduced growth and invasion in resistant cells.
-
Evidence date ·What can a worsening scan mean during cancer immunotherapy?
Review or Meta-AnalysisAcross trials reporting this outcome, 4.6% of patients had a response after scan-defined progression. Among a smaller group who continued treatment, 19.7% responded.